We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.55 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMTFB
RNS Number : 2659B
Motif Bio PLC
08 January 2018
Motif Bio plc
("Motif Bio" or the "Company")
Exercise of Warrants
Motif Bio plc (AIM/NASDAQ: MTFB), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced that it has received notification from a warrant holder to exercise warrants representing 471,602 ordinary shares of 1p each ("Ordinary Shares") in the Company at an exercise price of 20.0p per warrant for total consideration of GBP94,320.40.
Application has been made for the 471,602 new Ordinary Shares to be admitted to trading on AIM ("Admission"), which is expected to occur at 8.00 a.m. on January 11, 2018. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Following Admission, and for the purposes of the Disclosure Guidance and Transparency Rules, the Company's total issued share capital will consist of 263,990,730 Ordinary Shares. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the issued share capital of the Company.
For further information, please contact:
Motif Bio plc info@motifbio.com Graham Lumsden (Chief Executive Officer) Robert Dickey IV (Chief Financial Officer) Peel Hunt LLP (NOMAD & BROKER) + 44 (0)20 7418 8900 Dr Christopher Golden Oliver Jackson Northland Capital Partners Limited (BROKER) +44 (0)203 861 6625 Patrick Claridge/ David Hignell John Howes/ Rob Rees (Broking) Walbrook PR Ltd. +44 (0) 20 7933 8780 or motifbio@walbrookpr.com (FINANCIAL PR & IR) Paul McManus/Helen Cresswell/Lianne Cawthorne MC Services AG (EUROPEAN IR) +49 (0)89 210 2280 Raimund Gabriel raimund.gabriel@mc-services.eu The Trout Group (US + 1 (646) 378-2936 IR) Meggie Purcell mpurcell@troutgroup.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSSWFIAFASESF
(END) Dow Jones Newswires
January 08, 2018 10:23 ET (15:23 GMT)
1 Year Motif Bio Chart |
1 Month Motif Bio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions